Douglas E. Williams
2012 - Biogen
In 2012, Douglas E. Williams earned a total compensation of $4M as EVP, Research Development at Biogen, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $698,544 |
|---|---|
| Salary | $657,865 |
| Stock Awards | $2,486,226 |
| Other | $121,023 |
| Total | $3,963,658 |
Williams received $2.5M in stock awards, accounting for 63% of the total pay in 2012.
Williams also received $698.5K in non-equity incentive plan, $657.9K in salary and $121K in other compensation.
Rankings
In 2012, Douglas E. Williams' compensation ranked 1,663rd out of 11,487 executives tracked by ExecPay. In other words, Williams earned more than 85.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,663 out of 11,487 | 86th |
Division Manufacturing | 594 out of 4,253 | 86th |
Major group Chemicals And Allied Products | 134 out of 1,198 | 89th |
Industry group Drugs | 72 out of 920 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 11 out of 160 | 93rd |
Source: SEC filing on April 30, 2014.
Williams' colleagues
We found four more compensation records of executives who worked with Douglas E. Williams at Biogen in 2012.